Abstract-Following L-DOPA administration, DA metabolites were measured by both in vivo voltammetry and HPLC-ECD.
Abstract-Following
L-DOPA administration, DA metabolites were measured by both in vivo voltammetry and HPLC-ECD.
In vivo, the amplitudes of the catechol oxidation currents in both the striatum and frontal cortex increased and reached a plateau from 60 min to 240 min after L-DOPA treatment.
L-DOPA, DA, DOPAC and HVA levels measured by HPLC-ECD after L-DOPA treatment were increased in both regions, and the occurrence of the peak of each compound was dependent on its order in the metabolic pathway, i.e., 15 min for DA, 45 min for DOPAC and 60-180 min for HVA. However, NE remained unchanged.
No indication of a rapid DA increase was apparent in the catechol oxidation current at 15 min; and thus, DA is unlikely to be a main contributor to the catechol oxidation current in the brain of rats treated with L-DOPA.
In vivo application of differential pulse voltammetry in the brain of unanaesthetized freely moving rats has recently been developed (1-3); and with this method, it is possible to monitor changes in brain catechols and indoles (1, 3 Konig and Klippel (7) . Reference (Ag AgCI) and auxiliary (Ag) electrodes were placed on the surface of the cortex, and all the electrodes were fixed to the skull using dental cement. The animals were allowed to recover for 2 days before use. Voltammetric measurements were made (DPV-5, Tokai irika) with the following parameter settings based on Ikeda's report (3): potential sweep: -200 mV to +500 mV , pulse amplitude: 50 mV, scan rate: 25 mV/sec, pulse duration: 50 msec, sampling period: 20 msec, and a pulse frequency of 10 pulses/sec. To reduce interference by ascorbate, an oxidation potential (+50 mV) was applied to the working electrode for 3 min just before measurements were made. At the end of each experiment, electric lesions were made by passing a current (10 ,aA, 20 sec) through the working electrode and the location of the electrode tip was verified histologically.
Rats were sacrificed by microwave ir radiation at 1.5 kW for 1.3 sec (NJ E 2601, New Japan Radio Co., Ltd.) at various times after L-DOPA (200 mg/kg, i.p.) injection. The brains were removed, and tissue samples from the striatum and frontal cortex were dissected from two 600 ,um thick brain slices according to the atlas of Konig and Klippel by the addition of 0.25 N NaOH, and then 5 mg of activated alumina were added and the mixture was shaken for 15 min. After the aqueous phase was discarded, the alumina were washed 3 times with 500 /el of double distilled water. Following addition of 40 ul of 0.1 N HCI to the alumina, the super natant was applied to an HPLC column (Nucleosil 7C18). The mobile phase was 0.05 M phosphate buffer (pH 3.1, containing 10% methanol, 0.5 mM heptanesulfonic acid and 2 uM EDTA-2Na), The detector potential was set at +0.7 V versus an Ag/AgCI reference electrode, and the flow-rate was 0.8 ml/min.
For DOPAC and HVA assays, each tissue was sonicated in 100 PI of 0.1 N perchloric acid after addition of 20 ng 3,4-dihydroxy phenylpropionic acid in 10 al of perchloric acid as an internal standard. After 10 , l was taken for the protein assay, 50 i l of chloro form was added to the homogenates, and the mixture was vortexed and centrifuged at 6500 x g for 15 min. The supernatant was applied to the HPLC column (Nucleosil 7C18).
The mobile phase was 0.05 M phosphate buffer (pH 4.8, containing 20% methanol and 2 ,cM EDTA-2Na). The detector potential was set at +0.8 V versus an Ag/ AgCI reference electrode, and the flow-rate was 0.8 ml/min.
Protein was assayed according to the method of Lowry et al. (9) .
In a study using various solutions, L DOPA, DA, NE and DOPAC (dissolved in phosphate-buffered saline, pH 7.4) were detected at the catechol oxidation potential (approximately +100 mV). The highest detection sensitivity was found with DA; and the sensitivities of NE, L-DOPA and DOPAC were 84%, 8% and 2% of that of DA, respectively. 3 Methoxytyramine (3-MT) and HVA were detected at the indole oxidation potential (approximately +300 mV), and the sensitivities of 3-MT and HVA were 22% and 1 % of 5-hydroxytryptamine, respectively In vivo, the amplitudes of the catechol oxidation current after L-DOPA treatment in both the striatum and the frontal cortex were rapidly increased and reached a plateau from 60 min to 240 min (Fig. 1) .
L-DOPA, DA, DOPAC and HVA levels measured by HPLC-ECD after L-DOPA treatment were increased in both the striatum and frontal cortex; and the occurrence of the peak of each compound was dependent on its order in the metabolic pathway, i.e., 15 min for DA, 45 min for DOPAC and 60--180 min for HVA (Fig. 2) . However, NE remained unchanged (Fig. 2) .
Following L-DOPA injection, maximum increases in DA concentrations in both the striatum and frontal cortex were found after 15 min: they returned to the pre-injection levels by 120 min. However, at 15 min, no sign of a rapid DA increase was reflected in the catechol oxidation current even though the sensitivity of the electrode for DA is 50-fold higher than that for DOPAC: thus, after L-DOPA treatment, the amplitudes of the catechol oxidation currents at both sites increased smoothly until 60 min and plateaued thereafter. Our data supports the belief that L-DOPA is intracellularly decarboxylated to DA after it is taken up not only by dopami nergic neurones but also by glial cells (10) The high catechol oxidation current observed from 60 min to 240 min after L DOPA injection was not directly reflected by cerebral DOPAC concentrations. The maximum DOPAC levels in both the striatum and frontal cortex were found at 45 min and gradually decreased thereafter. Therefore, part of the DOPAC which may have diffused into the extracellular space is the possible main contributor to the catechol oxidation current. It can be assumed that this extra cellular DOPAC was detected by in vivo voltammetry just before it was converted to HVA since the pattern of the catechol oxidation current after L-DOPA treatment is between those of DOPAC and HVA.
